Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension

PHASE4TerminatedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Remodulin (treprostinil sodium)

Trial Locations (14)

Unknown

SAL Hospital & Medical Institute, Ahmedabad

Narayana Hrudayalaya Inst. Of Cardiac Sciences, Bangalore

Apollo Hospitals, Chennai

K. S. Hospital, Chennai

Sri Ramachandra Medical College, Chennai

Medwin Heart Institute, Hyderabad

Yashoda Super Specialty Hospital, Hyderabad

Apollo Gleneagles Hospital, Kolkata

KMC Hospital, Mangalore

Kasturba Medical College, Manipal

KEM Hospital, Mumbai

G. B. Pant Hospital & Maulana Azad Med. College, New Delhi

Ruby Hall Clinic, Pune

Krishna Institute of Medical Sciences, Secunderabad

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Asian Clinical Trials

UNKNOWN

lead

United Therapeutics

INDUSTRY

NCT00494533 - Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter